To confirm the safety of HT080 used in the treatment of BPH, the toxicity of HT080 in the liver was evaluated via ALT and AST, the two most important indices in predicting the risk or toxicity of a drug to the liver. Here, GPT is linked to benign prostatic hyperplasia.